| Identification | Back Directory | [Name]
(R*,R*)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate | [CAS]
183814-30-4 | [Synonyms]
Unii-W34shf8J2k
Formoterol hemifumar
Formoterol Fumarate (100 mg)
forMaMide fuMarate dihydrate
Formoterol fumarate dihydrate
Formoterol hemifumarate monohydrate
Formoterol fumarate dihydrate, >=99%
Formoterol fumarate dihydrate ,98.5%
Formoterol Fumarate Monohydrate/ dihydrate
Formoterol fumarate dihydrate Solution in Methanol, 100μg/mL
(±)-(R,R)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamidehemifumarate
R*)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate
N-(2-hydroxy-5-((R)-1-hydroxy-2-(((R)-1-(4-Methoxyphenyl)propan-2-yl)aMino)ethyl)phenyl)forMaMide fuMarate dihydrate
(r*,r*)-n-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrate
(R*,R*)-N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide fumarate dihydrateChemicalBook
Formamide, N-(2-hydroxy-5-((1R)-1-hydroxy-2-(((1R)-2-(4-methoxyphenyl)-1-methylethyl)amino)ethyl)phenyl)-, rel-, (2E)-2-butenedioate (2:1) (salt), dihydrate | [Molecular Formula]
2(C19H24N2O4).C4H4O4.2(H2O) | [MDL Number]
MFCD11045919 | [MOL File]
183814-30-4.mol | [Molecular Weight]
496.51 |
| Chemical Properties | Back Directory | [Melting point ]
116-120°C | [storage temp. ]
Store at RT | [solubility ]
DMSO: soluble20mg/mL | [form ]
solid | [color ]
white to off-white | [InChI]
InChI=1/C19H24N2O4.C4H4O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22;5-3(6)1-2-4(7)8/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t13-,19+;/s3 | [InChIKey]
RATSWNOMCHFQGJ-XODSYJLDSA-N | [SMILES]
C(/C(=O)O)=C\C(=O)O.[C@@H](C1C=CC(O)=C(NC=O)C=1)(O)CN[C@@H](C)CC1C=CC(OC)=CC=1 |&1:8,22,r| | [CAS DataBase Reference]
183814-30-4 |
| Hazard Information | Back Directory | [Chemical Properties]
Pale Yellow Solid | [Uses]
A selective β2-adrenergic receptor agonist. Used as an antiasthmatic. | [Uses]
ForMoterol FuMarate Dihydrate is a selective β2-adrenergic receptor agonist,it is used as an antiasthmatic.
| [Biological Activity]
Potent, selective and long-acting β 2 -adrenoceptor agonist. Displays 330-fold selectivity for β 2 over β 1 receptors (pK d values are 8.12 and 5.58 respectively). Potently relaxes guinea pig trachea (pD 2 = 9.29), and is longer-acting and 100-fold more potent than salbutamol. | [Biochem/physiol Actions]
β2-Adrenoreceptor agonist. | [Drug interactions]
The efficacy and tolerability of glycopyrronium/formoterol fumarate metered dose inhaler, a fixed-dose combination of glycopyrronium/formoterol fumarate dihydrate 14.4/10 μg (equivalent to glycopyrrolate/formoterol fumarate 18/9.6 μg) delivered by metered dose inhaler using innovative co-suspension delivery technology, was investigated in patients (n = 292) with COPD [12C]. There were no meaningful pharmacokinetic interactions, whether drug–drug or due to formulation, between glycopyrronium and formoterol following treatment with formulated using a new co-suspension delivery technology. The incidence of cardiovascular events of special interest was low (stroke, 0%–0.4%; cardiac ischemia, 0.4%–2.3%; cardiac failure, 1.3%–2.5%; arrhythmia, 1.3%–3.2%), and no important trends in clinical laboratory results, vital signs, or electrocardiograms were observed[1].
| [References]
[1] Aagaard, Lise . "A worldwide yearly survey of new data in adverse drug reactions." (2014).
|
|
|